Multicenter Study for the Validation of Willem AI: Aortic StenoSis Early Diagnosis With AI-electrocardiogram Study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Idoven 1903 S.L.
- Trial code
- NCT07479992
- Record updated
- 4 November 2026
- Original description
AoS-SEDAI study is an observational, multicenter, retrospective and prospective clinical study.Read full original descriptionShow less
Multicenter Study for the Validation of Willem AI: Aortic StenoSis Early Diagnosis With AI-electrocardiogram (Willem AoS-SEDAI) Study
AoS-SEDAI study is an observational, multicenter, retrospective and prospective clinical study.
This study aims to assess Willem Artificial Intelligence (AI) ability to distinguish between aortic stenosis (AS) and non-AS patients from 12-lead electrocardiogram (ECG) data.
Inclusion: Age ≥ 18 years; All available 12-lead ECG with a 10 seconds minimum length on raw data digital format will be included; Available clinical data corresponding to each ECG to confirm patient demographics and Aortic Stenosis diagnosis; Available transthoracic echocardiogram (TTE) within +/- 90 days of each ECG recording; No exclusion criteria are defined for this study.